Cargando…
Mannose-binding lectin-associated serine protease 2 (MASP-2) contributes to poor disease outcome in humans and mice with pneumococcal meningitis
BACKGROUND: Pneumococcal meningitis is the most common and severe form of bacterial meningitis. Fatality rates are substantial, and long-term sequelae develop in about half of survivors. Disease outcome has been related to the severity of the pro-inflammatory response in the subarachnoid space. The...
Autores principales: | Kasanmoentalib, E. Soemirien, Valls Seron, Mercedes, Ferwerda, Bart, Tanck, Michael W., Zwinderman, Aeilko H., Baas, Frank, van der Ende, Arie, Brouwer, Matthijs C., van de Beek, Diederik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234106/ https://www.ncbi.nlm.nih.gov/pubmed/28086930 http://dx.doi.org/10.1186/s12974-016-0770-9 |
Ejemplares similares
-
Erratum to: Mannose-binding lectin-associated serine protease 2 (MASP-2) contributes to poor disease outcome in humans and mice with pneumococcal meningitis
por: Kasanmoentalib, E. Soemirien, et al.
Publicado: (2017) -
Genetic Variation and Cerebrospinal Fluid Levels of Mannose Binding Lectin in Pneumococcal Meningitis Patients
por: Brouwer, Matthijs C., et al.
Publicado: (2013) -
Variation of 46 Innate Immune Genes Evaluated for their Contribution in Pneumococcal Meningitis Susceptibility and Outcome
por: Ferwerda, Bart, et al.
Publicado: (2016) -
V-akt murine thymoma viral oncogene homolog 3 (AKT3) contributes to poor disease outcome in humans and mice with pneumococcal meningitis
por: Valls Serón, Mercedes, et al.
Publicado: (2016) -
Adjuvant treatment with dexamethasone plus anti-C5 antibodies improves outcome of experimental pneumococcal meningitis: a randomized controlled trial
por: Kasanmoentalib, E. Soemirien, et al.
Publicado: (2015)